This inventor holds 1 USPTO granted patent. Top assignee: Minophagen Pharmaceutical Co., Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Hiroatsu Matsumoto: Innovator in Glycyrrhizin Research
Introduction
Hiroatsu Matsumoto is a notable inventor based in Zama, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the use of glycyrrhizin and its derivatives.
Latest Patents
Matsumoto holds a patent for the "Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors." The objective of this invention is to provide a method for inhibiting MCP-1 production, which is crucial for controlling the migration of monocytes or T lymphocytes in mammals. This patent outlines a pharmaceutical composition that effectively administers glycyrrhizin and its derivatives to achieve the desired inhibition.
Career Highlights
Matsumoto has dedicated his career to advancing pharmaceutical science. His work has focused on the therapeutic applications of glycyrrhizin, showcasing its potential in medical treatments. He is associated with Minophagen Pharmaceutical Co., Ltd., where he continues to innovate in the field.
Collaborations
Matsumoto has collaborated with notable colleagues, including Midori Takeda and Fujio Suzuki. Their combined expertise has contributed to the advancement of research in glycyrrhizin and its applications.
Conclusion
Hiroatsu Matsumoto is a distinguished inventor whose work in glycyrrhizin research has the potential to impact pharmaceutical treatments significantly. His contributions to the field are noteworthy and continue to inspire further innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile